「office」の検索結果
14件：6～10件目を表示
-
TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and licensed to Senju as...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
al for a BAC-free formulation of Aibeta® combination eye drops Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a p...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
al for a BAC-free formulation of Aibeta® combination eye drops Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a p...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
loping a compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) as an eye drop treatment...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
loping a compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) as an eye drop treatment...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf